Ophthotech reports lower revenue in second quarter

08:17 EDT 31 Jul 2017 | Healio

Ophthotech reported $1.7 million in collaboration revenue in the second quarter of 2017 compared with $28.2 million for the same period in 2016, according to a company press release.The decrease was attributed to “lower revenue from clinical drug supply shipments and due to the inclusion of the final enrollment-based clinical milestone under the company’s agreement with Novartis Pharma AG in 2016,” the release said.

Original Article: Ophthotech reports lower revenue in second quarter


More From BioPortfolio on "Ophthotech reports lower revenue in second quarter"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...